Association between peripheral blood biomarkers and diabetic macular edema
Acta Diabetologica · 23.09.2026
DOI: 10.1007/s00592-026-02799-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 23.09.2026. Verfasst von Ruowen Gong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute and Department of Ophthalmology, Eye and ENT Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of Chin…. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Lumitin Vision to Brightness Research Funding for the Young and Middle-aged Ophthalmologists, Shanghai Hospital Development Centre Foundation.
Abstract (Originalsprache)
AIM: To investigate the association between peripheral blood biomarkers and DME severity. METHODS: This cross-sectional study included 227 consecutive patients (305 eyes) with DME and 94 controls (94 eyes). DME was classified into early, advanced, and severe stages based on spectral-domain optical coherence tomography. Peripheral blood samples were analyzed, and the association between peripheral blood biomarkers and DME severity was evaluated using generalized estimating equations. RESULTS: Compared with the control group, patients with DME exhibited significantly lower values in red blood cell (RBC) count (P < 0.001), hemoglobin (P < 0.001) and hematocrit (P < 0.001), as well as significantly higher values in white blood cell count (P < 0.001), neutrophil count (P < 0.001), monocyte count (P < 0.001), fibrinogen level (P < 0.001), D-dimer level (P = 0.015), neutrophil-to-lymphocyte ratio (P < 0.001), and monocyte-to-lymphocyte ratio (P < 0.001). Moreover, advanced or severe DME was associated with RBC count (10^12/L) (OR (95% CI) = 0.49 (0.288, 0.834), P = 0.009), hemoglobin (g/L) (OR (95% CI) = 0.978 (0.959, 0.996), P = 0.02), and hematocrit (%) (OR (95% CI) = 0.919 (0.859, 0.985), P = 0.016). CONCLUSIONS: DME is characterized by reduced RBC measures and elevated inflammatory indices. Decreased RBC measures could serve as potential markers of DME severity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Eye Institute and Department of Ophthalmology, Eye and ENT Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
- NHC Key Laboratory of Myopia and Related Eye Disease, Chinese Academy of Medical Sciences, Shanghai, China.
- Eye Institute and Department of Ophthalmology, Eye and ENT Hospital of Fudan University, 83 Fenyang Road, Shanghai, 200031, People's Republic of China. drxugezhi@163.com.
- Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China. drxugezhi@163.com.
- NHC Key Laboratory of Myopia and Related Eye Disease, Chinese Academy of Medical Sciences, Shanghai, China. drxugezhi@163.com.
Förderung
- National Natural Science Foundation of China
- Lumitin Vision to Brightness Research Funding for the Young and Middle-aged Ophthalmologists
- Shanghai Hospital Development Centre Foundation
Zitieren
APA
Gong, R., Han, R., Li, H., Pan, M., Yang, X., Xu, G., & Liu, W. (2026). Association between peripheral blood biomarkers and diabetic macular edema. Acta Diabetologica. https://doi.org/10.1007/s00592-026-02799-x
Vancouver
Gong R, Han R, Li H, Pan M, Yang X, Xu G, et al. Association between peripheral blood biomarkers and diabetic macular edema. Acta Diabetologica. 2026. doi:10.1007/s00592-026-02799-x
BibTeX
@article{Gong2026,
author = {Gong, Ruowen and Han, Ruyi and Li, Han and Pan, Meidie and Yang, Xin and Xu, Gezhi and Liu, Wei},
title = {Association between peripheral blood biomarkers and diabetic macular edema},
journal = {Acta Diabetologica},
year = {2026},
doi = {10.1007/s00592-026-02799-x}
}
EUVIMED